Steven A. Kaplan

Active 1991–2026

109
Papers
18,803
Citations
74
h-index
105
i10-index

Citations

Citations per year for Steven A. Kaplan1992: 4 citations1993: 8 citations1994: 13 citations1995: 13 citations1996: 17 citations1997: 16 citations1998: 19 citations1999: 27 citations2000: 32 citations2001: 32 citations2002: 32 citations2003: 43 citations2004: 49 citations2005: 54 citations2006: 82 citations2007: 83 citations2008: 108 citations2009: 94 citations2010: 57 citations2011: 110 citations2012: 99 citations2013: 117 citations2014: 108 citations2015: 71 citations2016: 68 citations2017: 55 citations2018: 41 citations2019: 257 citations2020: 271 citations2021: 254 citations2022: 209 citations2023: 209 citations2024: 318 citations2025: 111 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,030 citing papers, 27.4% of this breakdownUnited Kingdom: 289 citing papers, 7.7% of this breakdownItaly: 264 citing papers, 7% of this breakdownChina: 244 citing papers, 6.5% of this breakdownCanada: 193 citing papers, 5.1% of this breakdownGermany: 173 citing papers, 4.6% of this breakdownNetherlands: 112 citing papers, 3% of this breakdownFrance: 99 citing papers, 2.6% of this breakdownJapan: 81 citing papers, 2.2% of this breakdownSpain: 78 citing papers, 2.1% of this breakdownSouth Korea: 77 citing papers, 2.1% of this breakdownSwitzerland: 74 citing papers, 2% of this breakdown
0%27.4%Other 27.7%

Fields

  • Medicine88.1%
  • Biochemistry, Genetics and Molecular Biology4.2%
  • Business, Management and Accounting2%
  • Health Professions1.4%
  • Economics, Econometrics and Finance1.1%
  • Neuroscience0.6%
  • Other2.6%

Topics

  • Urinary Bladder and Prostate Research22.2%
  • Pelvic floor disorders treatments11.3%
  • Prostate Cancer Diagnosis and Treatment10.1%
  • Sexual function and dysfunction studies7.4%
  • Urinary Tract Infections Management5.6%
  • Hormonal and reproductive studies4.1%
  • Other39.3%

Coauthors

All papers

Open in search
  1. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I—Initial Work-up and Medical Management

    Authors: , , , , , , , , , , , , , , - The Journal of Urology 2021 cited by 381

  2. Benign prostatic hyperplasia

    Authors: , , , , , , , - Nature Reviews Disease Primers 2016 cited by 450

  3. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study

    Authors: , , , , , , , , , , - British Journal of Urology 2009 cited by 793

  4. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II—Surgical Evaluation and Treatment

    Authors: , , , , , , , , , , , , , , - The Journal of Urology 2021 cited by 285

  5. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2003 cited by 2,040

  6. Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia

    Authors: , , , , , , , , , , , - The Journal of Urology 2011 cited by 1,427

  7. Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Enlargement

    Authors: , , , , , , , - European Urology 2010 cited by 634

  8. Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate Cancer

    Authors: , , , , , , - The Journal of Urology 1992 cited by 773

  9. WATER II (80–150 mL) procedural outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - British Journal of Urology 2018 cited by 89

  10. Rezum therapy for patients with large prostates (≥ 80 g): initial clinical experience and postoperative outcomes

    Authors: , , , , , , - World Journal of Urology 2021 cited by 75

  11. The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

    Authors: , , , , , , , , , , , , , , , , , , - The Journal of Urology 2023 cited by 40

  12. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline

    Authors: , , , , , , , , , , , , - The Journal of Urology 2018 cited by 324

  13. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis

    Authors: , , , , , , , , , , , - European Urology 2016 cited by 124

  14. Focal bladder neck cautery associated with low rate of post-Aquablation bleeding.

    Authors: , , , , , , , , , , , , - 2021 cited by 27

  15. Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS/BPH

    Authors: , , , , , , , , , - Prostate Cancer and Prostatic Diseases 2024 cited by 17

  16. Role of inflammation in benign prostatic hyperplasia.

    Authors: , , , - 2011 cited by 146

  17. One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia

    Authors: , , , , , - Prostate Cancer and Prostatic Diseases 2021 cited by 36

  18. Effect of Bothersome Overactive Bladder Symptoms on Health-related Quality of Life, Anxiety, Depression, and Treatment Seeking in the United States: Results From EpiLUTS

    Authors: , , , , - Urology 2012 cited by 272

  19. Lower Urinary Tract Symptoms Revisited: A Broader Clinical Perspective

    Authors: , , , , , , , - European Urology 2008 cited by 241

  20. Modern best practice in the management of benign prostatic hyperplasia in the elderly

    Authors: , , , - Therapeutic Advances in Urology 2020 cited by 65

  21. The state of TURP through a historical lens

    Authors: , - World Journal of Urology 2021 cited by 23

  22. A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

    Authors: , , , , , , , , , , - European Urology 2012 cited by 325

  23. Association of Nocturia and Mortality: Results From the Third National Health and Nutrition Examination Survey

    Authors: , , , , , - The Journal of Urology 2010 cited by 228

  24. The Age Related Decrease in Testosterone is Significantly Exacerbated in Obese Men With the Metabolic Syndrome. What are the Implications for the Relatively High Incidence of Erectile Dysfunction Observed in These Men?

    Authors: , , - The Journal of Urology 2006 cited by 183